Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - TAX PROVISION
Tax Provision DMAC - DiaMedica Therapeutics Inc.
43 K
LAST VALUE
23.92%
2 YEAR CAGR
-11.68%
5 YEAR CAGR
18.72%
10 YEAR CAGR